Cargando…
Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model
Immune modulation of the tumor microenvironment has been reported to participate in the therapeutic efficacy of many chemotherapeutic agents. Recently, we reported that liposomal encapsulation of oxaliplatin (l‐OHP) within PEGylated liposomes conferred a superior antitumor efficacy to free l‐OHP in...
Autores principales: | Shimizu, Taro, Abu Lila, Amr S., Nishio, Miho, Doi, Yusuke, Ando, Hidenori, Ukawa, Masami, Ishima, Yu, Ishida, Tatsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581521/ https://www.ncbi.nlm.nih.gov/pubmed/28643902 http://dx.doi.org/10.1111/cas.13305 |
Ejemplares similares
-
Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil(®)) in C26 Tumor-Bearing Immunocompetent Mice
por: Takayama, Takuma, et al.
Publicado: (2020) -
Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing
por: Doi, Yusuke, et al.
Publicado: (2016) -
Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways
por: Emam, Sherif E., et al.
Publicado: (2018) -
A Unique Gene-Silencing Approach, Using an Intelligent RNA Expression Device (iRed), Results in Minimal Immune Stimulation When Given by Local Intrapleural Injection in Malignant Pleural Mesothelioma
por: Ando, Hidenori, et al.
Publicado: (2020) -
PEGylated liposomes: immunological responses
por: Mohamed, Marwa, et al.
Publicado: (2019)